MaxCyte Quarterly Balance Sheet
NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MaxCyte financial position
As of Sep 30, 2026, MaxCyte reported total assets of $182.5 million, down 14.5% from a year earlier against total liabilities of $31.6 million. Shareholders' equity stood at $150.9 million, or 82.7% of assets. The company held $13.4 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 7.83, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
MaxCyte balance sheet (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 13.37M | 15.04M | 14.56M | 20.07M | 12.97M | 15.22M | 23.39M | 27.88M | 36.96M | 37.51M | 22.25M | 46.51M |
| Short-Term Investments | 87.91M | 90.65M | 92.30M | 82.98M | 92.75M | 111.34M | 114.89M | 126.60M | 116.87M | 119.82M | 135.26M | 121.78M |
| Receivables | 12.05M | 3.92M | 4.25M | 3.50M | 8.31M | 5.75M | 5.53M | 4.68M | 4.56M | 4.58M | 5.99M | 5.78M |
| Inventory | 7.38M | 7.80M | 7.63M | 7.55M | 7.61M | 7.93M | 8.27M | 8.91M | 10.39M | 11.16M | 11.96M | 12.23M |
| Total Current Assets | 124.67M | 121.27M | 122.94M | 118.37M | 124.64M | 143.22M | 155.75M | 171.68M | 172.91M | 175.65M | 178.67M | 190.19M |
| Property, Plant & Equipment | 14.34M | 14.90M | 16.64M | 17.53M | 18.62M | 19.40M | 19.92M | 19.71M | 20.97M | 21.72M | 22.80M | 23.51M |
| Goodwill | — | — | — | — | 3.55M | 3.75M | 3.92M | — | — | — | — | — |
| Intangible Assets | 749.00K | 766.00K | 783.00K | 650.00K | 667.00K | 638.00K | 498.00K | — | — | — | — | — |
| Long-Term Investments | 31.47M | 36.23M | 40.81M | 52.57M | 52.27M | 38.60M | 36.42M | 35.78M | 42.80M | 42.48M | 45.03M | 42.94M |
| Total Assets | 182.48M | 184.67M | 194.47M | 202.51M | 213.48M | 219.75M | 229.96M | 239.47M | 248.61M | 251.50M | 257.93M | 268.27M |
| Accounts Payable | 1.03M | 1.73M | 1.20M | 1.40M | 1.29M | 1.21M | 2.28M | 1.36M | 1.86M | 953.00K | 1.67M | 743.00K |
| Total Current Liabilities | 15.92M | 9.89M | 10.21M | 14.27M | 16.10M | 11.55M | 12.73M | 15.78M | 17.62M | 12.28M | 13.48M | 17.86M |
| Total Liabilities | 31.55M | 25.92M | 26.59M | 31.02M | 33.20M | 29.03M | 30.55M | 33.22M | 35.31M | 30.23M | 31.57M | 36.11M |
| Shareholders' Equity | 150.93M | 158.75M | 167.89M | 171.49M | 180.28M | 190.72M | 199.41M | 206.25M | 213.30M | 221.26M | 226.36M | 232.17M |
| Retained Earnings | -279.87M | -275.11M | -266.23M | -261.48M | -251.89M | -239.47M | -227.11M | -216.85M | -206.26M | -194.70M | -185.32M | -175.80M |
| Net Cash (Debt) | 101.28M | 105.69M | 106.85M | 103.04M | 105.73M | 126.56M | 138.27M | 154.48M | 153.83M | 157.33M | 157.51M | 168.29M |
| Shares Outstanding | 103.23M | 106.13M | 107.12M | 106.79M | 106.64M | 106.59M | 106.31M | 105.71M | 105.30M | 104.82M | 104.41M | 103.96M |
This table shows 12 quarterly periods of MaxCyte's balance sheet, from Q3 2026 back to Q4 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MXCT's reporting calendar. What is a balance sheet?